Navigation Links
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
Date:8/23/2007

FDA Approved Product Will Accelerate Growth of Pain Franchise

FRAZER, Pa., Aug. 23 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today it has signed an agreement to acquire the North American rights to AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals, a privately held company. Two dosage strengths of AMRIX (15 mg and 30 mg) were approved in February 2007 by the U.S. Food and Drug Administration (FDA) for short-term use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. The product is not yet available commercially in the United States; however, Cephalon expects to launch the product early in the fourth quarter.

Under the agreement, which is expected to close on or about August 28, 2007, Cephalon will acquire the rights to AMRIX for $100 million cash. The company also could make future cash payments to ECR upon the achievement of certain cumulative net sales milestones. The company anticipates that the transaction will be modestly dilutive in the fourth quarter due to product launch costs; despite this, the company is reaffirming its existing 2007 sales and adjusted income per common share guidance. The transaction is expected to be accretive in 2008 and thereafter.

"AMRIX is an excellent strategic fit with our current sales organization, providing us with a second product that is complementary to many pain relievers used today," said Robert Roche, Executive Vice President, Worldwide Pharmaceutical Operations. "Cyclobenzaprine HCl is the most widely prescribed muscle relaxant in the United States, representing 37 percent of the 45 million prescriptions for muscle relaxants written in 2006, according to IMS. AMRIX has convenient once-daily dosing and a side effect profile that includes very low rates of sedation which will provide physicians and patients an attractive alternative to current therapies.
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)...  iVinci Health LLC, the company behind the healthcare ... branded as VisitPay®, has successfully closed $5 million in ... a new extension to VisitPay® – an online Payment ... way for patients to manage their medical bills and ... their families. The new round of funding, ...
(Date:9/15/2014)... 2014 Applied Silicone Corporation, a ... the medical device and critical healthcare market, introduces ... implantable medical device market. The Dual Matrix ... a silicone gel with improved fracture resistance, cohesive ... consists of two crosslinked networks working in conjunction ...
(Date:9/15/2014)... ANNAPOLIS, Maryland , 15 de septiembre de 2014 /PRNewswire/ ... se llevará a cabo del 12 al 18 de ... Association (PPTA) y de sus compañías miembro s, ... de la concienciación mundial en torno a la colección de ... los donantes de plasma al salvar y mejorar las vidas ...
(Date:9/14/2014)... 15, 2014 UMBC’s Biotechnology Graduate ... Tuesday, October 21, 2014, from 12:00 to 1:00 p.m. ... program’s innovative curriculum and practice-oriented instruction, designed for working ... can help advance their career in the biotechnology industry. ... . , About UMBC’s Biotechnology Graduate Programs, UMBC ...
Breaking Biology Technology:iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... organizations see security and compliance as their top issues, they ... There is a big secret that few executives know about ... issue. It goes beyond knowing virus scans and firewalls. Security ... strategy and not a low-level function. , ,In several semesters ...
... trend away from IPOs and the progress of six regional ... Fund I annual meeting, held at the Wisconsin Athletic Club. ... Mason Wells met in Milwaukee to hear a speech ... Association , and listen to updates from six firms that ...
... Bone Care International Inc. announced on Wednesday that the ... ,Genzyme and Bone Care have signed a definitive agreement for ... transaction valued at $33.00 per fully diluted share. ... Care's shareholders at a meeting on June 30, and other ...
Cached Biology Technology:To find solid security candidates, look beyond tech certificates 2To find solid security candidates, look beyond tech certificates 3To find solid security candidates, look beyond tech certificates 4VC trends, company progress discussed at Mason Wells portfolio meeting 2VC trends, company progress discussed at Mason Wells portfolio meeting 3VC trends, company progress discussed at Mason Wells portfolio meeting 4
(Date:9/15/2014)... teeming with life it,s not what comes to mind ... time evidence of Doncaster,s 310-million-year-old past, including a fossilised shark ... , Some of the fossilised plants and creatures may even ... case, several horseshoe crabs and some previously unrecorded seed pods ... rocks that formed within the coal and shale deposits in ...
(Date:9/15/2014)... Amid conflicting reports about the need for vitamin ... published today suggests that adequate levels of this essential ... elderly, and women who are or may become pregnant. ... also important, researchers said, but often complicated by the ... difficult to obtain through diet alone. It has been ...
(Date:9/12/2014)... September 12, 2014 ... the addition of the  "Global Facial Recognition ... and Facial Analytics) - Industry Analysis, Size, ... 2020"  report to their offering. ... facial recognition market was valued at USD ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3
... As governments prepare to gather at the United ... and 20, a new report published by a group ... evidence that a combined approach to tackling poverty and ... education, and nutrition/food securityachieves better results for the world,s ...
... which extends to include the formal scientific naming of all ... in the procedure scientists need to follow when they describe ... ,International Code of Nomenclature for algae, fungi and plants, are ... article published in BioMed Central,s open access journal BMC ...
... for Research on Aging (Novato, CA) and Biotica Technology ... investigate polyketides in diseases of aging. Building on observations ... & Kennedy; Nature 2009), the collaborators will ... range of age-related disease models to identify novel therapeutics. ...
Cached Biology News:Report showcases success of integrated development approaches 2Report showcases success of integrated development approaches 3Bringing botany into the 21st Century 2Buck Institute and Biotica to investigate polyketides in extension of healthy lifespan 2